QS-21 adjuvant derived from saponins from the bark of Quillaja saponaria tree data

A trial published in The New England Journal of Medicine showed best results when a vaccine against malaria made by SmithKline Beecham Biologicals (Rixensart, Belgium)

Read the full 253 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE